Parenteral Formulation Stability
Parenteral Formulation Stability is the scientific assessment of the maintenance of physicochemical and microbiological integrity of a parenteral formulation under specified storage conditions over time, distinguishing it from other pharmaceutical stability evaluations by its exclusive focus on sterile, non-oral dosage forms intended for administration via routes such as intravenous, intramuscular, or subcutaneous injection.
65
Publications
1.7K
Citations
277
Authors
113
Institutions
Publications per year
2017–2026
7
65
Optimization of a Series of RIPK2 PROTACs
Afjal H. Miah, Ian E. Smith, M.D. Rackham et al. · Journal of Medicinal Chemistry · 2021 · 67 citations · Full text
1–5 of 65
277
2
h-index
2
h-index
2
h-index
2
h-index
2
h-index
1–5 of 277
113

Slotervaartziekenhuis
Amsterdam, Netherlands
3 h-index
6 publications
129 citations

University of Toronto
Toronto, Canada
3 h-index
8 publications
133 citations
University of Connecticut
Storrs, United States
2 h-index
2 publications
129 citations

St. Louis Children's Hospital
St Louis, United States
2 h-index
6 publications
108 citations
Center for Drug Evaluation and Research
Silver Spring, United States
2 h-index
4 publications
258 citations
Eli Lilly (United States)
Indianapolis, United States
2 h-index
5 publications
94 citations
Utrecht University
Utrecht, The Netherlands
2 h-index
4 publications
147 citations

Gdańsk Medical University
Gdansk, Poland
2 h-index
5 publications
68 citations
1–8 of 113
AJHP · 8 publications · 160 citations
9
h-index
Repository · 9 publications · 194 citations
9
h-index
5 publications · 122 citations
5
h-index
4 publications · 87 citations
4
h-index
4 publications · 126 citations
4
h-index
1–5